HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

bafilomycin C1

structure given in first source

Also Known As:

bafilomycin-C1

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Lactones: 1549
  - Macrolides: 4391
    - bafilomycin C1: 1
  - Polyketides: 231
    - Macrolides: 4391
      - bafilomycin C1: 1
Polycyclic Compounds: 6
- Macrocyclic Compounds: 15
  - Polyketides: 231
    - Macrolides: 4391
      - bafilomycin C1: 1

Experts

1.	Ding, Nan: 1 article (01/2018)
2.	Gao, Xiaoxiao: 1 article (01/2018)
3.	Guan, Peipei: 1 article (01/2018)
4.	Han, Li: 1 article (01/2018)
5.	Hu, Caijuan: 1 article (01/2018)
6.	Huang, Xueshi: 1 article (01/2018)
7.	Mu, Yu: 1 article (01/2018)

Related Diseases

1.	Neoplasms (Cancer) 01/01/2018 - "Cell-cycle arrest and induced apoptosis in tumor tissues in a mouse model treated with bafilomycin C1 were demonstrated by histological analyses, western blot and TUNEL. " 01/01/2018 - "In vivo experiments in mice suggested that bafilomycin C1 suppressed tumor growth with few side effects. " 01/01/2018 - "Bafilomycin C1, which was isolated from Streptomyces albolongus in our previous work, exhibited strong cytotoxicity against several cancer cell lines. " 01/01/2018 - "These findings indicate that bafilomycin C1 may be a promising candidate for hepatic cellular cancer therapy."
2.	Liver Neoplasms (Liver Cancer) 01/01/2018 - "Bafilomycin C1 induces G0/G1 cell-cycle arrest and mitochondrial-mediated apoptosis in human hepatocellular cancer SMMC7721 cells."

Related Therapies and Procedures

1.	Therapeutics